about
Elucidating the signal responses of multi-parametric surface plasmon resonance living cell sensing: a comparison between optical modeling and drug-MDCKII cell interaction measurementsFeasibility Study of the Permeability and Uptake of Mesoporous Silica Nanoparticles across the Blood-Brain BarrierInkjet printing of drug substances and use of porous substrates-towards individualized dosing.Fluorescence-suppressed time-resolved Raman spectroscopy of pharmaceuticals using complementary metal-oxide semiconductor (CMOS) single-photon avalanche diode (SPAD) detector.Single exosome study reveals subpopulations distributed among cell lines with variability related to membrane contentPrinting technologies in fabrication of drug delivery systems.Rational design of liposomal drug delivery systems, a review: Combined experimental and computational studies of lipid membranes, liposomes and their PEGylation.Microvesicle- and exosome-mediated drug delivery enhances the cytotoxicity of Paclitaxel in autologous prostate cancer cells.Control of the morphology of lipid layers by substrate surface chemistry.Cholesterol level affects surface charge of lipid membranes in saline solution.Oncolytic adenoviruses coated with MHC-I tumor epitopes increase the antitumor immunity and efficacy against melanoma.Application of paper-supported printed gold electrodes for impedimetric immunosensor development.Characterization of phosphatidylcholine/polyethylene glycol-lipid aggregates and their use as coatings and carriers in capillary electrophoresis.Molecular organization of the tear fluid lipid layer.Label-enhanced surface plasmon resonance: a new concept for improved performance in optical biosensor analysis.Immobilization of alcohol dehydrogenase in phospholipid Langmuir-Blodgett films to detect ethanol.Cobalt nanoparticle Langmuir-Schaefer films on ethylene glycol subphase.Molecular-level interactions of an azopolymer and poly(dodecylmethacrylate) in mixed Langmuir and Langmuir-Blodgett films for optical storage.The interaction of an antiparasitic peptide active against African sleeping sickness with cell membrane models.Cholesterol mediates chitosan activity on phospholipid monolayers and Langmuir-Blodgett films.Silymarin loaded liposomes for hepatic targeting: in vitro evaluation and HepG2 drug uptake.Characterizing ultrathin and thick organic layers by surface plasmon resonance three-wavelength and waveguide mode analysis.Non-labeled monitoring of targeted liposome interactions with a model receptor surface: effect of flow rate and water content.Interfacial approach to polyaromatic hydrocarbon toxicity: phosphoglyceride and cholesterol monolayer response to phenantrene, anthracene, pyrene, chrysene, and benzo[a]pyrene.Enhancement of Bioavailability and Pharmacodynamic Effects of Thymoquinone Via Nanostructured Lipid Carrier (NLC) Formulation.Enhanced activity of horseradish peroxidase in Langmuir-Blodgett films of phospholipids.Chitosan as a removing agent of beta-lactoglobulin from membrane models.Optical properties of thermally responsive amphiphilic gold nanoparticles protected with polymers.Interactions of fusidic acid and elongation factor G with lipid membranes.An impedance QCM study on the partitioning of bioactive compounds in supported phospholipid bilayers.Membrane bound COMT isoform is an interfacial enzyme: general mechanism and new drug design paradigm.Interaction of lecithin-cholesterol acyltransferase with lipid surfaces and apolipoprotein A-I derived peptides.Real-Time Label-Free Monitoring of Nanoparticle Cell Uptake.Indocyanine Green-Loaded Liposomes for Light-Triggered Drug Release.Ionic liquids affect the adsorption of liposomes onto cationic polyelectrolyte coated silica evidenced by quartz crystal microbalance.Multi-parametric surface plasmon resonance platform for studying liposome-serum interactions and protein corona formation.An impedimetric study of DNA hybridization on paper-supported inkjet-printed gold electrodes.Targeting Tumor-Associated Exosomes with Integrin-Binding PeptidesHigh-Generation Amphiphilic Janus-Dendrimers as Stabilizing Agents for Drug SuspensionsPersonalized Cancer Vaccine Platform for Clinically Relevant Oncolytic Enveloped Viruses
P50
Q27309042-D9CE4955-105B-466F-9EC6-03E7D26C2DAAQ27330313-C648E608-A087-48FA-9810-EAF8A874C830Q34167620-EBD81109-78F8-4BBE-B24D-1C4CDCC443A4Q35835479-8745AD4A-B550-4BF2-AE96-140F34B3F191Q35864064-A63B03D9-9959-4400-8AD5-F8AEC57E9E90Q38164422-2716D85C-9FAC-40C9-8F89-A4ED4E5EE5B9Q38750218-162BD3FC-05E2-489C-BEBB-6B2647084EC3Q38833830-A7083110-3B4A-48FB-858B-0F9BCAF74F8BQ39021366-E289A891-DCFC-48EF-8EB2-48CB461058E6Q39818318-F805E549-5EAA-4FC9-A210-F16B22C1E54FQ40438006-834E9007-8937-4FED-8CB9-F49F77249661Q41584522-F5CE7535-08B6-4AE7-BDC6-232FD32AA27FQ41623396-38B9A4DC-3347-455F-94E1-716295C05629Q41899472-1FB65A29-816F-4B0A-BCF5-700B9BB14902Q41943527-89560020-3D01-4F49-9636-A696E94A58A1Q42168827-5BB55E88-E37B-4C4C-ADF0-9A73C098493BQ42945470-C7C08794-DD09-477F-AEC6-8FDADF10C7F4Q43118488-4BC5F187-B5C7-43DC-9C15-14C0EA21EA70Q43281230-84118450-E18E-4269-BC17-97EB26B2557DQ43286410-63349F21-624F-47DC-9D18-065D39B8FA91Q44244993-8304B977-51FE-4647-B348-46A088D1DE1DQ44477291-808D8C62-39E6-4823-A817-1C3E542F12CAQ45211128-2BBE7BAA-32B7-4CCE-873D-E531F7FE2158Q46332994-02F0F1B7-D2CD-4610-BFE9-E989FE366493Q46337926-CD9048FE-59ED-4560-950C-A8724A54CFEEQ46664822-B56EAB9E-4E31-4941-9CEA-CD08F50E017AQ46732036-B5A31DDB-77FA-41E1-B09F-2F42580F8051Q46885703-31D2A109-1F0B-45F4-A4DF-DF521239CE84Q46916190-CBA3FEAE-F549-4BD8-A311-3793F1431CB7Q48265536-432FC0BC-C2C4-493D-A8F6-00AA03D86ECDQ49994687-CD5BC46B-05CC-4951-988C-FFEE18D713DEQ50036912-9DC6CB57-942F-4BD2-8DDD-9C856EF3AC39Q50227934-D28067B5-E40F-40D9-AA2B-127713FB2611Q50229420-67F7BBC0-3B42-4DBF-8F47-BC34DCCFA2C6Q50242362-F520FD18-E941-48B9-85F6-C906D7EA4057Q51594610-ECCC92F7-C412-4D15-AA93-38ACDA80E934Q53621432-929B13F7-9261-4D51-8A1F-21082C41A875Q56889136-0AE62DC1-33D4-4A15-A8CA-A6BCEEBE6DE1Q57180502-EE581640-7B47-4BA1-9249-57C12602D6F1Q59356992-D906A74D-6CF4-48B7-9073-3BD4860EB0CD
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Tapani Viitala
@ast
Tapani Viitala
@en
Tapani Viitala
@es
Tapani Viitala
@sl
type
label
Tapani Viitala
@ast
Tapani Viitala
@en
Tapani Viitala
@es
Tapani Viitala
@sl
altLabel
Tappi
@en
prefLabel
Tapani Viitala
@ast
Tapani Viitala
@en
Tapani Viitala
@es
Tapani Viitala
@sl
P1053
N-1434-2014
P106
P1153
55912253100
P21
P31
P3829
P4012
P496
0000-0001-9074-9450
P569
2000-01-01T00:00:00Z